RDY:NYSE
Dr Reddy's Laboratories Ltd
$11.71
arrow_downward
-1.43%(-0.17) 1D
$11.80
arrow_upward
+0.77% (+0.090)todayPre-market
Closed: Sep 10, 4:00:05 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RDY...
Open
$11.86
High
$11.86
Low
$11.67
Mkt. cap
9.92B
Avg. vol.
2.54M
Volume
1.69K
Dividend
0.71%
Quarterly dividend
$0.02
Ex-dividend date
Jul 10, 2026
P/E ratio
28.03
52-wk high
$15.67
52-wk low
$11.36
EPS
$0.42
Beta
0.30
Shares outstanding
834.64M
No. of employees
28K
Open
$11.86
High
$11.86
Low
$11.67
Mkt. cap
9.92B
Avg. vol.
2.54M
Volume
1.69K
Dividend
0.71%
Quarterly dividend
$0.02
Ex-dividend date
Jul 10, 2026
P/E ratio
28.03
52-wk high
$15.67
52-wk low
$11.36
EPS
$0.42
Beta
0.30
Shares outstanding
834.64M
No. of employees
28K
News stories
From web sources and news partners
TechGraph
·
1 hour ago
Dr. Reddy’s Laboratories Share Price Today (DRREDDY) | Live Chart, News & Stock Market
TipRanks
·
17 hours ago
Dr. Reddy’s Schedules September Analyst and Investor Meetings
TipRanks
·
17 hours ago
Dr. Reddy’s Issues New ESOP Shares After ADR Option Exercise
Stock Titan
·
18 hours ago
Dr. Reddy’s (NYSE: RDY) adds 375 shares via employee options
Profile
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
About Dr Reddy's Laboratories Ltd
CEOErez Israeli
Employees27.5K
Founded1984
HeadquartersHyderabad, Andhra Pradesh, India
SectorPharmaceutical industry
Websitedrreddys.com